Unknown

Dataset Information

0

Interpretation of health-related quality of life outcomes in Parkinson's disease from the EARLYSTIM Study.


ABSTRACT: The EARLYSTIM Study compared deep brain stimulation (DBS) with best medical treatment (BMT) over 2-years, showing a between-group difference of 8.0 from baseline in favor of DBS in health-related quality of life (HRQoL), measured with the PDQ-39 SI (summary index). This study obtained complementary information about the importance of the change in HRQoL as measured by the PDQ-39, using anchor-based (Patient Global Impression of Change, PGIC) and distribution-based techniques (magnitude of change, effect size, thresholds, distribution of benefit) applied to the EARLYSTIM study data. Anchor-based techniques showed a difference follow-up-baseline for patients who reported "minimal improvement" of -5.8 [-9.9, -1.6] (mean [95%CI]) in the DBS group vs -2.9 [-9.0, 3.1] in the BMT group. As the vast majority (80.8%) of DBS patients reported "much or very much improvement", this difference was explored for the latter group and amounted to -8.7 for the DBS group and -6.5 in the BMT group. Distribution-based techniques that analyzed the relative change and treatment effect size showed a moderate benefit of the DBS on the HRQoL, whereas a slight worsening was observed in the BMT group. The change in the DBS group (-7.8) was higher than the MIC (Minimally Important Change) estimated value (-5.8 by the anchor; -6.3 by triangulation of thresholds), but not in the BMT (0.2 vs. -3.0 to -5.4, respectively). Almost 90% of the patients in the DBS group declared some improvement (58.3% and 56.7% beyond the estimated MIC), which was significantly different from the BMT group whose proportions were 32.0% and 30.3%, respectively. The number needed to treat to improve ?1 MIC by DBS vs BMT was 3.8. Change in depression, disability and pain influenced the improvement of the DBS group. DBS improved HRQoL in a high proportion of patients to a significant and moderate degree, at 2 years follow-up.

SUBMITTER: Martinez-Martin P 

PROVIDER: S-EPMC7442251 | biostudies-literature | 2020

REPOSITORIES: biostudies-literature

altmetric image

Publications

Interpretation of health-related quality of life outcomes in Parkinson's disease from the EARLYSTIM Study.

Martinez-Martin Pablo P   Deuschl Guenther G   Tonder Lisa L   Schnitzler Alfons A   Houeto Jean-Luc JL   Timmermann Lars L   Rau Joern J   Schade-Brittinger Carmen C   Stoker Valerie V   Vidailhet Marie M   Krack Paul P  

PloS one 20200821 8


The EARLYSTIM Study compared deep brain stimulation (DBS) with best medical treatment (BMT) over 2-years, showing a between-group difference of 8.0 from baseline in favor of DBS in health-related quality of life (HRQoL), measured with the PDQ-39 SI (summary index). This study obtained complementary information about the importance of the change in HRQoL as measured by the PDQ-39, using anchor-based (Patient Global Impression of Change, PGIC) and distribution-based techniques (magnitude of change  ...[more]

Similar Datasets

| S-EPMC2900393 | biostudies-other
| S-EPMC9306816 | biostudies-literature
| S-EPMC8345955 | biostudies-literature
| S-EPMC6164202 | biostudies-other
| S-EPMC5106304 | biostudies-literature
| S-EPMC6307132 | biostudies-literature
| S-EPMC10763356 | biostudies-literature
| S-EPMC6093079 | biostudies-literature
| S-EPMC5484474 | biostudies-literature
| S-EPMC8077086 | biostudies-literature